COVID-19 mild to moderate | COVID-19 severe or critically | ||
COVID 19 hospitalized | COVID-19 mild to moderate | COVID-19 severe or critically | |
lopinavir/ritonavir | SOLIDARITY ... Nojomi Ader ... RECOVERY | ELACOI ... | REMAP-CAP ... Cao |
5210 | Ye et al., 2020 | 2 | 99 | 0 | excluded | not a RCT | risk of bias not avaialble |
6751 | Chen_lopi_rito, 2020 | 1 | 13 | 4 | not a RCT | high risk of bias |